Newron Pharma Delays Schizophrenia Trials Over Safety Concerns 0 28.05.2019 03:00 Feedity.com The agency expressed concern over the results of recently finished studies in rats and dogs that showed central nervous system events that might have implications in humans. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа